Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 5/20 | 0.64 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.64 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.64 |
| ▸ | AMY2A | P04746 | 4/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.54 |
| ▸ | CD69 | Q07108 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.48 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.47 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.47 |
| ▸ | HPSE | Q9Y251 | 2/20 | 0.47 |
| ▸ | CD209 | Q9NNX6 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6471615 | 1.00 | LGALS3 (0.64) | LGALS3LGALS8LGALS4AMY2AMAPK1 | |
| SCHEMBL31694310 | 1.00 | LGALS3 (0.64) | LGALS3LGALS8LGALS4AMY2AMAPK1 | |
| SCHEMBL6122661 | 1.00 | LGALS3 (0.64) | LGALS3LGALS8LGALS4AMY2AMAPK1 | |
| SCHEMBL7717429 | 1.00 | LGALS3 (0.64) | LGALS3LGALS8LGALS4AMY2AMAPK1 | |
| SCHEMBL31701078 | 0.97 | LGALS3 (0.61) | LGALS3LGALS8LGALS4AMY2AMAPK1 | |
| SCHEMBL30527803 | 0.97 | LGALS3 (0.61) | LGALS3LGALS8LGALS4AMY2AMAPK1 | |
| SCHEMBL5525281 | 0.97 | LGALS3 (0.68) | LGALS3LGALS8LGALS4AMY2AMAPK1 | |
| SCHEMBL6816305 | 0.97 | LGALS3 (0.68) | LGALS3LGALS8LGALS4AMY2AMAPK1 | |
| SCHEMBL31700985 | 0.95 | LGALS3 (0.59) | LGALS3LGALS8LGALS4AMY2AMAPK1 | |
| SCHEMBL31700839 | 0.95 | LGALS3 (0.61) | LGALS3LGALS8LGALS4AMY2AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025032055-A1 | CYCLIC CARBAMATE COMPOUNDS FOR LIGATION | CARBOCALYX GMBH (DE) | 2025-02-13 | — | — | WO | claimed |
| WO-2025032055-A1 | CYCLIC CARBAMATE COMPOUNDS FOR LIGATION | CARBOCALYX GMBH (DE) | 2025-02-13 | — | — | WO | disclosed |
| US-20020142046-A1 | Protein particles for therapeutic and diagnostic use | YEN, RICHARD C.K. | 2002-10-03 | — | — | US | disclosed |
| US-6391343-B1 | PARTICLE COMPRISING FIBRINOGEN BOUND ON SURFACE OF ALBUMIN MATRIX, CAPABLE OF CO-AGGREGATION WITH PLATELETS, AND OF AGGREGATION IN SOLUTION CONTAINING SOLUBLE FIBRINOGEN AT CONCENTRATION NOT CAPABLE OF CLOT FORMATION BY ITSELF | HEMOSPHERE, INC. | 2002-05-21 | — | — | US | disclosed |
| US-5945033-A | ALBUMIN, HEMOGLOBIN MIXTURE; STABILITY | HEMOSPHERE, INC. (US) | 1999-08-31 | — | — | US | disclosed |
| US-5725804-A | ALBUMIN PARTICLES STABLE TO RESOLUBILIZATION, POLYOXYETHYLENE GLYCOL, ALCOHOL | HEMOSPHERE, INC. (US) | 1998-03-10 | — | — | US | disclosed |
| US-5616311-A | AQUEOUS ALBUMIN SUSPENSION STABILIZED BY HEMOGLOBIN PARTICLES | HEMOSPHERE, INC. (US) | 1997-04-01 | — | — | US | disclosed |